The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

Those requirements can make it more difficult to access Spravato. Some people also experience uncomfortable side effects from oral antidepressants, such as weight gain, decreased libido, or mood ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

We have made great strides in the medical community, with people having access to life-saving physical drugs as well as mental health medicine. A recent approval made by the FDA could be a great step ...

Here's what doctors want you to know about Spravato, plus potential side effects to be aware of. Thea Gallagher, PsyD, is a clinical associate professor at NYU Langone Health and cohost of the ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral antidepressants.

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the immediate impact Spravato has had on patients with treatment-resistant ...

These side effects and the potential risk of harmful dependence have led to the FDA mandating a special treatment strategy for providing Spravato to patients, known as a Risk Evaluation and ...

Spravato targets glutamate in the brain, which is the most abundant excitatory neurotransmitter. Since there are some side effects, including sedation, respiratory depression and misuse ...

Spravato does have some risks. It can cause side effects like drowsiness, dissociation, or respiratory depression. There’s also the chance it could be misused. Because of this, Spravato is only ...

21, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application (sNDA) for SPRAVATO ...

The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...